Skip to main content
. 2021 Oct 8;9:e12262. doi: 10.7717/peerj.12262

Figure 1. WIN does not modulate ACE2 in hiPSC-CMs.

Figure 1

(A) Relative mRNA expression levels of ACE2 in WIN-treated hiPSC-CMs expressed as fold change relative to untreated condition. (B) Quantification of western blots by densitometry normalized by actin expression. ACE2 mRNA and protein levels were comparable between WIN-treated and untreated hiPSC-CMs. Error bars represent standard errors of the means (SEMs) from three (A) and four (B) independent experiments (three or four cellular differentiations) from one cell line.